Breaking News Instant updates and real-time market news.

VLO

Valero

$58.75 /

-4.56 (-7.20%)

05:57
05/04/20
05/04
05:57
05/04/20
05:57

Valero upgraded to Buy from Neutral at Mizuho

Mizuho analyst Paul Sankey upgraded Valero Energy to Buy from Neutral with an $85 price target.

VLO Valero
$58.75 /

-4.56 (-7.20%)

04/30/20 Wells Fargo
Valero price target raised to $70 from $65 at Wells Fargo
04/21/20 Jefferies
Phillips 66 Partners, Valero downgraded to Hold at Jefferies
04/21/20 Jefferies
Valero downgraded to Hold from Buy at Jefferies
03/26/20 Jefferies
Jefferies cuts Midstream & Refining estimates, but upgrades 5 'attractive' names

TODAY'S FREE FLY STORIES

General news
Asian Market Update: » 01:55
04/13/21
04/13
01:55
04/13/21
01:55
$ECON

Economic Data

/

+

Asian Market Update:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
    General news
    U.S. CPI preview » 01:55
    04/13/21
    04/13
    01:55
    04/13/21
    01:55
    $ECON

    Economic Data

    /

    +

    U.S. CPI preview:…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
      Recommendations
      Reviews of Tela Bio's OviTex from two KOLs were positive, says Piper Sandler » 20:58
      04/12/21
      04/12
      20:58
      04/12/21
      20:58
      TELA

      Tela Bio

      $13.58 /

      + (+0.00%)

      Piper Sandler analyst…

      Piper Sandler analyst Matt O'Brien keeps his Overweight rating and $20 price target on Tela Bio after the company-hosted investor call featuring two key opinion leaders discussing their use of the company's OviTex in treating hernias. The clinicians used the product in hundreds of procedures ranging from simple cases to complex procedures, the analyst tells investors in a research note, adding that he was "struck by the enthusiasm" that both of the surgeons had for the product and the low recurrence rates in procedures using OviTex compared to competitive meshes.

      ShowHide Related Items >><<
      TELA Tela Bio
      $13.58 /

      + (+0.00%)

      TELA Tela Bio
      $13.58 /

      + (+0.00%)

      04/01/21 Piper Sandler
      Integra to benefit from FDA safety communication, says Piper Sandler
      03/25/21 Canaccord
      Tela Bio pieces in place for accelerating growth, says Canaccord
      01/14/21 Piper Sandler
      Piper says Tela Bio momentum looks 'healthy' despite 'slight' Q4 miss
      11/11/20 Piper Sandler
      Tela Bio price target raised to $20 from $17 at Piper Sandler
      TELA Tela Bio
      $13.58 /

      + (+0.00%)

      • 26
        Jun
      Recommendations
      New CEO at Amarin to facilitate continued growth, says Piper Sandler » 20:53
      04/12/21
      04/12
      20:53
      04/12/21
      20:53
      AMRN

      Amarin

      $5.85 /

      -0.09 (-1.52%)

      Piper Sandler analyst…

      Piper Sandler analyst Yasmeen Rahimi keeps her Overweight rating and $19 price target on Amarin after the company announced that Karim Mikhail would succeed John Thero as CEO later this year. The Street was surprised by the announcement, the analyst tells investors in a research note, but she believes that his deep commercial expertise will facilitate Amarin's continued growth, especially ahead of VAZKEPA's E.U. launch in Q3 of this year.

      ShowHide Related Items >><<
      AMRN Amarin
      $5.85 /

      -0.09 (-1.52%)

      AMRN Amarin
      $5.85 /

      -0.09 (-1.52%)

      04/06/21 Piper Sandler
      Amarin 'one step closer' to multi-billion opportunity, says Piper Sandler
      02/25/21 Piper Sandler
      Amarin to have strong execution year ahead, says Piper Sandler
      02/01/21 Piper Sandler
      Matinas trial shows 'robust' serum increass despite miss, says Piper Sandler
      01/29/21 Piper Sandler
      Amarin's EU approval 'guaranteed' after CHMP nod, says Piper Sandler
      AMRN Amarin
      $5.85 /

      -0.09 (-1.52%)

      AMRN Amarin
      $5.85 /

      -0.09 (-1.52%)

      AMRN Amarin
      $5.85 /

      -0.09 (-1.52%)

      AMRN Amarin
      $5.85 /

      -0.09 (-1.52%)

      Downgrade
      NorthWestern downgraded to Neutral from Outperform at Credit Suisse » 20:46
      04/12/21
      04/12
      20:46
      04/12/21
      20:46
      NWE

      NorthWestern

      $67.70 /

      +0.79 (+1.18%)

      Credit Suisse analyst…

      Credit Suisse analyst Michael Weinstein downgraded NorthWestern to Neutral from Outperform with a price target of $66, up from $60. The analyst says his rating change is driven by valuation following the recent period of outperformance in the stock.

      ShowHide Related Items >><<
      NWE NorthWestern
      $67.70 /

      +0.79 (+1.18%)

      NWE NorthWestern
      $67.70 /

      +0.79 (+1.18%)

      03/23/21 BofA
      NorthWestern upgraded to Neutral from Underperform at BofA
      12/04/20
      Fly Intel: Top five analyst initiations
      12/04/20 KeyBanc
      NorthWestern initiated with an Overweight at KeyBanc
      11/18/20 Barclays
      NorthWestern downgraded to Equal Weight from Overweight at Barclays
      NWE NorthWestern
      $67.70 /

      +0.79 (+1.18%)

      Upgrade
      MFA Financial upgraded to Outperform from Market Perform at Keefe Bruyette » 20:43
      04/12/21
      04/12
      20:43
      04/12/21
      20:43
      MFA

      MFA Financial

      $4.18 /

      +0.005 (+0.12%)

      Keefe Bruyette analyst…

      Keefe Bruyette analyst Bose George upgraded MFA Financial to Outperform from Market Perform with a $4.75 price target.

      ShowHide Related Items >><<
      MFA MFA Financial
      $4.18 /

      +0.005 (+0.12%)

      11/23/20 BTIG
      MFA Financial initiated with a Buy at BTIG
      08/24/20 JMP Securities
      MFA Financial upgraded to Outperform from Market Perform at JMP Securities
      08/24/20 JMP Securities
      MFA Financial upgraded to Outperform from Market Perform at JMP Securities
      04/13/20 JMP Securities
      MFA Financial downgraded to Market Perform from Outperform at JMP Securities
      MFA MFA Financial
      $4.18 /

      +0.005 (+0.12%)

      MFA MFA Financial
      $4.18 /

      +0.005 (+0.12%)

      Downgrade
      Cadence Bancorp downgraded to Sector Perform from Outperform at RBC Capital » 20:42
      04/12/21
      04/12
      20:42
      04/12/21
      20:42
      CADE

      Cadence Bancorp

      $22.41 /

      +0.92 (+4.28%)

      RBC Capital analyst Jon…

      RBC Capital analyst Jon Arfstrom downgraded Cadence Bancorp to Sector Perform from Outperform with a $25 price target.

      ShowHide Related Items >><<
      CADE Cadence Bancorp
      $22.41 /

      +0.92 (+4.28%)

      CADE Cadence Bancorp
      $22.41 /

      +0.92 (+4.28%)

      02/23/21 Stephens
      Stephens raises Regions price target to $23, sees possible deal for Cadence
      08/18/20 Keefe Bruyette
      Cadence Bancorp upgraded to Outperform from Market Perform at Keefe Bruyette
      08/14/20 Truist
      Cadence Bancorp upgraded to Buy from Hold at Truist
      08/14/20 Truist
      Cadence Bancorp upgraded to Buy from Hold at Truist
      CADE Cadence Bancorp
      $22.41 /

      +0.92 (+4.28%)

      CADE Cadence Bancorp
      $22.41 /

      +0.92 (+4.28%)

      Initiation
      Identiv initiated with a Buy at B. Riley » 20:29
      04/12/21
      04/12
      20:29
      04/12/21
      20:29
      INVE

      Identiv

      $11.75 /

      +0.25 (+2.17%)

      B. Riley analyst Craig…

      B. Riley analyst Craig Ellis initiated coverage of Identiv with a Buy rating and $21 price target.

      ShowHide Related Items >><<
      INVE Identiv
      $11.75 /

      +0.25 (+2.17%)

      INVE Identiv
      $11.75 /

      +0.25 (+2.17%)

      09/28/20 Northland
      Identiv benefitting as Apple supports NFC, says Northland
      09/22/20 Lake Street
      Identiv price target raised to $8 after management meeting at Lake Street
      INVE Identiv
      $11.75 /

      +0.25 (+2.17%)

      • 08
        Apr
      Hot Stocks
      Lyft CFO sells 15K shares of common stock » 20:27
      04/12/21
      04/12
      20:27
      04/12/21
      20:27
      LYFT

      Lyft

      $59.82 /

      -1.14 (-1.87%)

      In a regulatory filing,…

      In a regulatory filing, Lyft disclosed that its CFO Brian Roberts sold 15K shares of common stock on April 8th in a total transaction size of $919.9K, reducing his stake by about 1%.

      ShowHide Related Items >><<
      LYFT Lyft
      $59.82 /

      -1.14 (-1.87%)

      LYFT Lyft
      $59.82 /

      -1.14 (-1.87%)

      04/05/21 Evercore ISI
      Lyft assumed with an Outperform at Evercore ISI
      03/31/21 Wolfe Research
      Lyft assumed with a Peer Perform at Wolfe Research
      03/26/21
      Fly Intel: Top five analyst initiations
      03/26/21 Vertical Research
      Lyft initiated with a Buy at Vertical Research
      LYFT Lyft
      $59.82 /

      -1.14 (-1.87%)

      LYFT Lyft
      $59.82 /

      -1.14 (-1.87%)

      LYFT Lyft
      $59.82 /

      -1.14 (-1.87%)

      LYFT Lyft
      $59.82 /

      -1.14 (-1.87%)

      Upgrade
      FedEx upgraded to Overweight from Sector Weight at KeyBanc » 20:25
      04/12/21
      04/12
      20:25
      04/12/21
      20:25
      FDX

      FedEx

      $290.86 /

      +4.335 (+1.51%)

      KeyBanc analyst Todd…

      KeyBanc analyst Todd Fowler upgraded FedEx to Overweight from Sector Weight with a $350 price target. The analyst is citing the proprietary Online Parcel Index suggesting that B2C parcel volumes remained strong throughout Q1. Fowler adds that the positive trends around more resilient airfreight dynamics, leverage to improving global economic activity, and rational pricing dynamics should persist and "more than offset" any potential impact from a return to in-person shopping and service spending.

      ShowHide Related Items >><<
      FDX FedEx
      $290.86 /

      +4.335 (+1.51%)

      FDX FedEx
      $290.86 /

      +4.335 (+1.51%)

      04/12/21 KeyBanc
      FedEx upgraded to Overweight from Sector Weight at KeyBanc
      04/08/21 JPMorgan
      FedEx added to Analyst Focus List as value idea at JPMorgan
      03/26/21
      Fly Intel: Top five analyst initiations
      03/26/21 Vertical Research
      FedEx initiated with a Buy at Vertical Research
      FDX FedEx
      $290.86 /

      +4.335 (+1.51%)

      FDX FedEx
      $290.86 /

      +4.335 (+1.51%)

      FDX FedEx
      $290.86 /

      +4.335 (+1.51%)

      FDX FedEx
      $290.86 /

      +4.335 (+1.51%)

      Hot Stocks
      Innovent/Eli Lilly's phase 3 study of TYVYT in sqNSCLC saw OS improvement » 20:05
      04/12/21
      04/12
      20:05
      04/12/21
      20:05
      IVBXF

      Innovent Biologics

      $13.00 /

      + (+0.00%)

      , LLY

      Eli Lilly

      $181.76 /

      -2.71 (-1.47%)

      Innovent Biologics…

      Innovent Biologics (IVBXF) announced with Eli Lilly (LLY) that the results of the Phase 3 ORIENT-3 study were released today in an oral presentation at the American Association for Cancer Research Annual Meeting 2021. ORIENT-3 is a randomized, open-label, Phase 3 clinical trial evaluating TYVYT, or sintilimab injection, versus docetaxel as a second-line treatment for advanced or metastatic squamous non-small cell lung cancer, or sqNSCLC. A total of 290 patients whose cancer had progressed following first-line treatment with platinum-based chemotherapy were enrolled. Based on the primary analysis population, TYVYT demonstrated a statistically significant improvement in overall survival, or OS, compared to docetaxel, meeting the pre-specified primary endpoint. The median OS was 11.79 months for patients on the TYVYT arm and 8.25 months for those on the docetaxel arm. The median progression-free survival as assessed by investigators was 4.30 months versus 2.79 months, and the confirmed objective response rate was 25.5% versus 2.2%, respectively. Safety was consistent with previous studies of TYVYT, and no new safety signals were identified.

      ShowHide Related Items >><<
      LLY Eli Lilly
      $181.76 /

      -2.71 (-1.47%)

      IVBXF Innovent Biologics
      $13.00 /

      + (+0.00%)

      11/03/20 Daiwa
      Innovent Biologics initiated with a Buy at Daiwa
      07/08/20 JPMorgan
      Innovent Biologics downgraded to Neutral from Overweight at JPMorgan
      LLY Eli Lilly
      $181.76 /

      -2.71 (-1.47%)

      04/12/21 Benchmark
      Benchmark sees full FDA approval of Regeneron's REGEN-COV coming
      04/06/21 JPMorgan
      JPMorgan survey 'broadly positive' on Eli Lilly Alzheimer's drug
      03/24/21 BMO Capital
      AbCellera price target lowered to $59 from $61 at BMO Capital
      03/17/21 Mizuho
      AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
      LLY Eli Lilly
      $181.76 /

      -2.71 (-1.47%)

      LLY Eli Lilly
      $181.76 /

      -2.71 (-1.47%)

      LLY Eli Lilly
      $181.76 /

      -2.71 (-1.47%)

      LLY Eli Lilly
      $181.76 /

      -2.71 (-1.47%)

      Hot Stocks
      Opendoor Technologies up 1.5% afterhours after ARK Investment ETF trade update » 19:33
      04/12/21
      04/12
      19:33
      04/12/21
      19:33
      OPEN

      Opendoor Technologies

      $19.40 /

      -1.1 (-5.37%)

      Shares of Opendoor…

      Shares of Opendoor Technologies are up 1.5% afterhours at $19.70. In its daily evening update, ARK Investment Management disclosed a Buy of 633.4K shares of common stock.

      ShowHide Related Items >><<
      OPEN Opendoor Technologies
      $19.40 /

      -1.1 (-5.37%)

      OPEN Opendoor Technologies
      $19.40 /

      -1.1 (-5.37%)

      03/18/21
      Fly Intel: Top five analyst initiations
      03/18/21 Citi
      Opendoor Technologies initiated with a Buy at Citi
      03/05/21 Oppenheimer
      Opendoor Technologies price target lowered to $30 from $34 at Oppenheimer
      03/01/21 Credit Suisse
      Opendoor Technologies initiated with an Outperform at Credit Suisse
      OPEN Opendoor Technologies
      $19.40 /

      -1.1 (-5.37%)

      • 05
        Feb
      OPEN Opendoor Technologies
      $19.40 /

      -1.1 (-5.37%)

      OPEN Opendoor Technologies
      $19.40 /

      -1.1 (-5.37%)

      OPEN Opendoor Technologies
      $19.40 /

      -1.1 (-5.37%)

      Upgrade
      FedEx upgraded to Overweight from Sector Weight at KeyBanc » 19:25
      04/12/21
      04/12
      19:25
      04/12/21
      19:25
      FDX

      FedEx

      $290.86 /

      +4.335 (+1.51%)

      KeyBanc analyst Todd…

      KeyBanc analyst Todd Fowler upgraded FedEx to Overweight from Sector Weight.

      ShowHide Related Items >><<
      FDX FedEx
      $290.86 /

      +4.335 (+1.51%)

      FDX FedEx
      $290.86 /

      +4.335 (+1.51%)

      04/08/21 JPMorgan
      FedEx added to Analyst Focus List as value idea at JPMorgan
      03/26/21
      Fly Intel: Top five analyst initiations
      03/26/21 Vertical Research
      FedEx initiated with a Buy at Vertical Research
      03/22/21 Argus
      FedEx underperformance offers buying opportunity, says Argus
      FDX FedEx
      $290.86 /

      +4.335 (+1.51%)

      FDX FedEx
      $290.86 /

      +4.335 (+1.51%)

      FDX FedEx
      $290.86 /

      +4.335 (+1.51%)

      FDX FedEx
      $290.86 /

      +4.335 (+1.51%)

      Hot Stocks
      Agilent CEO sells 15,095 shares of common stock » 19:20
      04/12/21
      04/12
      19:20
      04/12/21
      19:20
      A

      Agilent

      $131.25 /

      -0.635 (-0.48%)

      In a regulatory filing,…

      In a regulatory filing, Agilent disclosed that its CEO Michael McMullen sold 15,095 shares of common stock on April 8th in a total transaction size of $1.97M, reducing his stake by about 5%.

      ShowHide Related Items >><<
      A Agilent
      $131.25 /

      -0.635 (-0.48%)

      A Agilent
      $131.25 /

      -0.635 (-0.48%)

      03/18/21
      Fly Intel: Top five analyst upgrades
      03/18/21 Citi
      Agilent upgraded to Buy from Neutral at Citi
      03/18/21 Citi
      Agilent upgraded to Buy from Neutral at Citi
      02/17/21 Baird
      Agilent price target raised to $137 from $133 at Baird
      A Agilent
      $131.25 /

      -0.635 (-0.48%)

      A Agilent
      $131.25 /

      -0.635 (-0.48%)

      A Agilent
      $131.25 /

      -0.635 (-0.48%)

      Hot Stocks
      Mesa Air reports 28.1K block hours in March, down 15.9% from last year » 19:05
      04/12/21
      04/12
      19:05
      04/12/21
      19:05
      MESA

      Mesa Air

      $12.38 /

      -0.58 (-4.48%)

      Mesa Air Group reported…

      Mesa Air Group reported Mesa Airlines' operating performance for March 2021. Mesa Airlines reported 28,127 block hours in March 2021, a 15.9% drop from March 2020 "as a result of reduced schedules during the COVID-19 pandemic. The company also reported a controllable completion factor of 99.86 percent and 100 percent for its American and United operations, respectively. For Q2 of fiscal year 2021 ending March 31st, total block hours were 73,942 on 35,270 departures. These block hours are well below our guidance provided on our Q1 fiscal year 2021 Earnings Release. The reduced block hours and departures were the result of the mid-February major winter storm and subsequent Texas power outages impacting our major operations in both Dallas and Houston. During that period, we cancelled almost 1,300 flights representing close to 3,000 block hours while still incurring crew costs."

      ShowHide Related Items >><<
      MESA Mesa Air
      $12.38 /

      -0.58 (-4.48%)

      MESA Mesa Air
      $12.38 /

      -0.58 (-4.48%)

      03/04/21
      Fly Intel: Top five analyst downgrades
      03/04/21 Deutsche Bank
      Mesa Air downgraded to Hold after 100% rally at Deutsche Bank
      03/03/21 Deutsche Bank
      Mesa Air downgraded to Hold from Buy at Deutsche Bank
      02/17/21
      Fly Intel: Top five analyst upgrades
      MESA Mesa Air
      $12.38 /

      -0.58 (-4.48%)

      MESA Mesa Air
      $12.38 /

      -0.58 (-4.48%)

      MESA Mesa Air
      $12.38 /

      -0.58 (-4.48%)

      Initiation
      Tetra Tech initiated with a Hold at Vertical Research » 18:56
      04/12/21
      04/12
      18:56
      04/12/21
      18:56
      TTEK

      Tetra Tech

      $143.60 /

      +0.87 (+0.61%)

      Vertical Research analyst…

      Vertical Research analyst Michael Dudas initiated coverage of Tetra Tech with a Hold rating and $145 price target.

      ShowHide Related Items >><<
      TTEK Tetra Tech
      $143.60 /

      +0.87 (+0.61%)

      TTEK Tetra Tech
      $143.60 /

      +0.87 (+0.61%)

      02/01/21 Roth Capital
      Tetra Tech price target raised to $135 from $98 at Roth Capital
      01/15/21 Maxim
      Tetra Tech price target raised to $155 from $140 at Maxim
      11/12/20 Maxim
      Tetra Tech price target raised to $135 from $110 at Maxim
      11/09/20 Stifel
      Tetra Tech upgraded to Buy from Hold at Stifel
      TTEK Tetra Tech
      $143.60 /

      +0.87 (+0.61%)

      TTEK Tetra Tech
      $143.60 /

      +0.87 (+0.61%)

      Hot Stocks
      Air Canada enters into debt, equity financing agreement with Canadian government » 18:54
      04/12/21
      04/12
      18:54
      04/12/21
      18:54
      ACDVF

      Air Canada

      $21.53 /

      +0.1401 (+0.65%)

      Air Canada announced that…

      Air Canada announced that it has entered into a series of debt and equity financing agreements with the Government of Canada, which will allow Air Canada to access up to C$5.879B in liquidity through the Large Employer Emergency Financing Facility program. "Air Canada entered the pandemic more than a year ago with one of the global airline industry's strongest balance sheets relative to its size. We have since raised an additional $6.8 billion in liquidity from our own resources to sustain us through the pandemic, as air traffic ground to a virtual halt in Canada and internationally," said Michael Rousseau, President and Chief Executive Officer of Air Canada. "The additional liquidity program we are announcing today achieves several aligned objectives as it provides a significant layer of insurance for Air Canada, it enables us to better resolve customer refunds of non-refundable tickets, maintain our workforce and re-enter regional markets. Most importantly, this program provides additional liquidity, if required, to rebuild our business to the benefit of all stakeholders and to remain a significant contributor to the Canadian economy through its recovery and for the long term. As vaccine deployments ramp up, we continue to work with the Government of Canada on the evolution of safe and science-based test and quarantine relief measures with a view to safely restarting our sector. We know that Canadians are looking forward to re-connecting with friends and family and taking those long-awaited vacations and business trips and we will be ready to safely connect Canadians within Canada and Canada to the world," said Rousseau.

      ShowHide Related Items >><<
      ACDVF Air Canada
      $21.53 /

      +0.1401 (+0.65%)

      ACDVF Air Canada
      $21.53 /

      +0.1401 (+0.65%)

      04/09/21 CIBC
      Air Canada price target raised to C$34 from C$28 at CIBC
      04/08/21 National Bank
      Air Canada downgraded to Sector Perform from Outperform at National Bank
      03/16/21 TD Securities
      Air Canada downgraded to Hold from Buy at TD Securities
      03/12/21 Scotiabank
      Air Canada downgraded to Sector Perform from Outperform at Scotiabank
      ACDVF Air Canada
      $21.53 /

      +0.1401 (+0.65%)

      Hot Stocks
      FDA grants Akouos orphan drug designation in OTOF-mediated hearing loss » 18:54
      04/12/21
      04/12
      18:54
      04/12/21
      18:54
      AKUS

      Akouos

      $14.52 /

      +0.66 (+4.76%)

      On a post on the…

      On a post on the FDA's website, Akouos' treatment for otoferlin gene (OTOF)-mediated hearing loss was granted orphan drug designation. Reference Link

      ShowHide Related Items >><<
      AKUS Akouos
      $14.52 /

      +0.66 (+4.76%)

      AKUS Akouos
      $14.52 /

      +0.66 (+4.76%)

      04/05/21
      Akouos management to meet virtually with BTIG
      03/30/21 BofA
      Akouos downgraded to Neutral at BofA on OTOF IND filing delay
      03/30/21 BofA
      Akouos downgraded to Neutral from Buy at BofA
      08/13/20 Piper Sandler
      Akouos gearing up for 'busy' couple of years, says Piper Sandler
      AKUS Akouos
      $14.52 /

      +0.66 (+4.76%)

      • 26
        Jun
      Hot Stocks
      Air France-KLM, China Eastern Airlines extend scope of partnership » 18:41
      04/12/21
      04/12
      18:41
      04/12/21
      18:41
      AFLYY

      Air France-KLM

      $6.28 /

      -0.225 (-3.46%)

      In the context of the…

      In the context of the participation of China Eastern Airlines to the share capital increase of Air France-KLM, both airline groups have decided to extend the scope of their partnership through: an intensified commercial cooperation and an extended collaboration to noncommercial related activities, and; an increased footprint on the Beijing market, with the Paris-Beijing and Amsterdam-Beijing routes joining the current Joint Venture existing between Air France-KLM and China Eastern Airlines when conditions are satisfied.

      ShowHide Related Items >><<
      AFLYY Air France-KLM
      $6.28 /

      -0.225 (-3.46%)

      AFLYY Air France-KLM
      $6.28 /

      -0.225 (-3.46%)

      03/23/21 Citi
      Citi opens '90-day negative Catalyst Watc' on Air France-KLM
      03/15/21 UBS
      Air France-KLM price target raised to EUR 4.35 from EUR 4.15 at UBS
      02/22/21 Deutsche Bank
      Air France-KLM price target lowered to EUR 2.70 from EUR 3.50 at Deutsche Bank
      02/16/21 Bernstein
      Air France-KLM downgraded to Underperform from Market Perform at Bernstein
      AFLYY Air France-KLM
      $6.28 /

      -0.225 (-3.46%)

      Hot Stocks
      Vasta Platform CFO Clovis Poggetti Junior resigns, Bruno Giardino to succeed » 18:30
      04/12/21
      04/12
      18:30
      04/12/21
      18:30
      VSTA

      Vasta Platform

      $9.30 /

      +0.13 (+1.42%)

      Vasta Platform announced…

      Vasta Platform announced the resignation for personal reasons of Clovis Poggetti Junior as its CFO and investor relations officer and the appointment of Bruno Giardino to serve as the company's CFO and investor relations officer. Clovis Poggetti Junior will continue in the company until April 23, during which period he will transfer his activities to Bruno Giardino. Giardino joins the company after having served as the investor relations officer for the company's parent company, Cogna Educacao S.A., since March 2020.

      ShowHide Related Items >><<
      VSTA Vasta Platform
      $9.30 /

      +0.13 (+1.42%)

      VSTA Vasta Platform
      $9.30 /

      +0.13 (+1.42%)

      12/17/20 Scotiabank
      Vasta Platform initiated with an Outperform at Scotiabank
      08/25/20 UBS
      Vasta Platform initiated with a Buy at UBS
      08/25/20 Morgan Stanley
      Vasta Platform initiated with an Overweight at Morgan Stanley
      08/25/20 BofA
      Vasta Platform initiated with a Buy at BofA
      VSTA Vasta Platform
      $9.30 /

      +0.13 (+1.42%)

      • 31
        Jul
      Hot Stocks
      Safeguard Scientifics exits ownership of stake in Zipnosis » 18:29
      04/12/21
      04/12
      18:29
      04/12/21
      18:29
      SFE

      Safeguard Scientifics

      $6.45 /

      -0.155 (-2.35%)

      The company states:…

      The company states: "Safeguard Scientifics announced the exit of our ownership interest in Zipnosis. Safeguard received $3.3M of initial cash proceeds and a preferred equity interest in Bright Health Group, a national integrated healthcare company. The majority of the consideration we received in the transaction is reflected in this preferred equity interest. Additional cash proceeds may be received from the final determinations of net working capital and the resolution of various escrow contingencies. Safeguard will report a gain on the sale of the Zipnosis ownership interest for the quarter ended March 31, 2021, based on the total value received from the transaction."

      ShowHide Related Items >><<
      SFE Safeguard Scientifics
      $6.45 /

      -0.155 (-2.35%)

      On The Fly
      Fly Intel: After-Hours Movers » 18:25
      04/12/21
      04/12
      18:25
      04/12/21
      18:25
      MFNC

      Mackinac Financial

      $13.26 /

      -0.23 (-1.70%)

      , RILY

      B. Riley Financial

      $60.92 /

      -0.51 (-0.83%)

      , OTIC

      Otonomy

      $2.21 /

      -0.015 (-0.67%)

      , ZUO

      Zuora

      $16.48 /

      +0.045 (+0.27%)

      , SLP

      Simulations Plus

      $63.41 /

      +1.45 (+2.34%)

      , FBIO

      Fortress Biotech

      $5.47 /

      +0.02 (+0.37%)

      , NI

      NiSource

      $24.74 /

      +0.045 (+0.18%)

      , SCKT

      Socket Mobile

      $7.17 /

      -0.69 (-8.78%)

      , CHWY

      Chewy

      $84.02 /

      +0.03 (+0.04%)

      ShowHide Related Items >><<
      ZUO Zuora
      $16.48 /

      +0.045 (+0.27%)

      SLP Simulations Plus
      $63.41 /

      +1.45 (+2.34%)

      SCKT Socket Mobile
      $7.17 /

      -0.69 (-8.78%)

      RILY B. Riley Financial
      $60.92 /

      -0.51 (-0.83%)

      OTIC Otonomy
      $2.21 /

      -0.015 (-0.67%)

      NI NiSource
      $24.74 /

      +0.045 (+0.18%)

      MFNC Mackinac Financial
      $13.26 /

      -0.23 (-1.70%)

      FBIO Fortress Biotech
      $5.47 /

      +0.02 (+0.37%)

      CHWY Chewy
      $84.02 /

      +0.03 (+0.04%)

      MFNC Mackinac Financial
      $13.26 /

      -0.23 (-1.70%)

      RILY B. Riley Financial
      $60.92 /

      -0.51 (-0.83%)

      OTIC Otonomy
      $2.21 /

      -0.015 (-0.67%)

      02/22/21 Piper Sandler
      Otonomy price target lowered to $5 from $10 at Piper Sandler
      12/18/20 H.C. Wainwright
      Otonomy price target raised to $10 from $9 at H.C. Wainwright
      12/17/20 Piper Sandler
      Piper says Otonomy's OTO-413 appears active, peak sales 'not accounted for'
      11/04/20 Piper Sandler
      Piper Sandler likes risk/reward on Otonomy ahead of two readouts by year-end
      ZUO Zuora
      $16.48 /

      +0.045 (+0.27%)

      04/08/21 Berenberg
      Zuora initiated with a Buy at Berenberg
      02/24/21 Jefferies
      Zuora price target raised to $17 from $13 at Jefferies
      12/04/20 Canaccord
      Zuora risk/reward attractive into next year, says Canaccord
      06/29/20 Goldman Sachs
      Zuora price target raised to $11 from $10 at Goldman Sachs
      SLP Simulations Plus
      $63.41 /

      +1.45 (+2.34%)

      01/12/21
      Fly Intel: Top five analyst downgrades
      01/12/21 Craig-Hallum
      Simulations Plus downgraded to Hold from Buy at Craig-Hallum
      01/12/21 Oppenheimer
      Simulations Plus price target raised to $85 from $79 at Oppenheimer
      11/25/20 Taglich Brothers
      Simulations Plus upgraded to Buy from Speculative Buy at Taglich Brothers
      FBIO Fortress Biotech
      $5.47 /

      +0.02 (+0.37%)

      04/05/21 B. Riley
      Fortress Biotech price target raised to $9 from $8 at B. Riley
      02/17/21 Dawson James
      Fortress Biotech price target raised to $21 from $16 at Dawson James
      12/14/20 Benchmark
      Decision looms on Fortress' Caelum after partner Alexion bought, says Benchmark
      10/13/20 B. Riley
      Fortress Biotech weakness on Avenue CRL overblown, says B. Riley Securities
      NI NiSource
      $24.74 /

      +0.045 (+0.18%)

      03/22/21 UBS
      NiSource upgraded to Buy from Neutral at UBS
      01/28/21 Goldman Sachs
      NiSource downgraded to Neutral from Buy at Goldman Sachs
      11/18/20 Barclays
      NiSource upgraded to Overweight from Equal Weight at Barclays
      10/19/20 BofA
      NiSource upgraded to Buy from Neutral at BofA
      SCKT Socket Mobile
      $7.17 /

      -0.69 (-8.78%)

      CHWY Chewy
      $84.02 /

      +0.03 (+0.04%)

      04/05/21 Evercore ISI
      Chewy assumed with an Outperform at Evercore ISI
      03/31/21 Wolfe Research
      Chewy initiated with a Peer Perform at Wolfe Research
      03/31/21 Wedbush
      Chewy price target raised to $100 from $90 at Wedbush
      03/31/21 Jefferies
      Chewy price target raised to $105 from $100 at Jefferies
      ZUO Zuora
      $16.48 /

      +0.045 (+0.27%)

      SLP Simulations Plus
      $63.41 /

      +1.45 (+2.34%)

      SCKT Socket Mobile
      $7.17 /

      -0.69 (-8.78%)

      RILY B. Riley Financial
      $60.92 /

      -0.51 (-0.83%)

      OTIC Otonomy
      $2.21 /

      -0.015 (-0.67%)

      NI NiSource
      $24.74 /

      +0.045 (+0.18%)

      FBIO Fortress Biotech
      $5.47 /

      +0.02 (+0.37%)

      CHWY Chewy
      $84.02 /

      +0.03 (+0.04%)

      • 20
        Apr
      • 08
        Apr
      • 13
        Jan
      • 17
        Sep
      • 06
        Aug
      • 09
        Jul
      CHWY Chewy
      $84.02 /

      +0.03 (+0.04%)

      ZUO Zuora
      $16.48 /

      +0.045 (+0.27%)

      SCKT Socket Mobile
      $7.17 /

      -0.69 (-8.78%)

      RILY B. Riley Financial
      $60.92 /

      -0.51 (-0.83%)

      OTIC Otonomy
      $2.21 /

      -0.015 (-0.67%)

      CHWY Chewy
      $84.02 /

      +0.03 (+0.04%)

      ZUO Zuora
      $16.48 /

      +0.045 (+0.27%)

      SLP Simulations Plus
      $63.41 /

      +1.45 (+2.34%)

      FBIO Fortress Biotech
      $5.47 /

      +0.02 (+0.37%)

      CHWY Chewy
      $84.02 /

      +0.03 (+0.04%)

      Conference/Events
      Morgan Stanley IT hardware analyst to hold analyst/industry conference call » 18:09
      04/12/21
      04/12
      18:09
      04/12/21
      18:09
      DELL

      Dell Technologies

      $93.47 /

      -0.415 (-0.44%)

      IT Hardware Analyst…

      IT Hardware Analyst Huberty, along with Sam Burd, President of Client Solutions Group at Dell, discuss the future of work on an Analyst/Industry conference call.

      ShowHide Related Items >><<
      DELL Dell Technologies
      $93.47 /

      -0.415 (-0.44%)

      DELL Dell Technologies
      $93.47 /

      -0.415 (-0.44%)

      04/08/21 Morgan Stanley
      Dell Technologies price target raised to $107 from $98 at Morgan Stanley
      04/07/21 Deutsche Bank
      Dell Technologies price target raised to $100 from $94 at Deutsche Bank
      02/26/21 JPMorgan
      Dell Technologies price target raised to $98 from $90 at JPMorgan
      02/26/21 Credit Suisse
      Dell Technologies price target raised to $80 from $70 at Credit Suisse
      DELL Dell Technologies
      $93.47 /

      -0.415 (-0.44%)

      DELL Dell Technologies
      $93.47 /

      -0.415 (-0.44%)

      DELL Dell Technologies
      $93.47 /

      -0.415 (-0.44%)

      DELL Dell Technologies
      $93.47 /

      -0.415 (-0.44%)

      Conference/Events
      Morgan Stanley Euro capital goods analyst holds analyst/industry conference call » 18:07
      04/12/21
      04/12
      18:07
      04/12/21
      18:07

      European Capital Goods…

      European Capital Goods Analyst Carrier, along with Andrew Bright, Managing Director at Woodside Capital Partners, discuss a $500B investment opportunity in the US/European Electrical Grid on an Analyst/Industry conference call to be held on April 13 at 9 am.

      Conference/Events
      Morgan Stanley energy analysts to hold analyst/industry conference call » 18:04
      04/12/21
      04/12
      18:04
      04/12/21
      18:04

      India/South East Asia…

      India/South East Asia Energy Analyst Maheshwari, Lead Commodity Strategist for Natural Gas & Power McDermott and Head European Energy Research Analyst Rats discuss the Energy Industry on an Analyst/Industry conference call to be held on April 13 at 9 am.

      Get Full Fly Access

      Breaking market intelligence sent straight to you
      Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
      Up-to-date information on important industry events
      Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
      News focused on the companies in your portfolio
      Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.